Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-09Clinical Trial Update: A Pilot Trial of Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) to Enhance Motor Learning in Progressive Multiple Sclerosis (MS) [NA]
Pilot trial evaluating remotely-supervised transcranial direct current stimulation to enhance motor learning in progressive multiple scleros…
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis [Phase 4]
Phase 4 clinical trial assessing sequential natalizumab and alemtuzumab therapy in relapsing multiple sclerosis has completed with results p…
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: Virtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological Disorders [NA]
A completed clinical trial evaluating virtual reality to improve quality of life in patients with neurological conditions, including multipl…
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: A Safety and Efficacy Study of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment [Phase 3]
Phase 3 trial of ADS-5102 in multiple sclerosis patients with walking impairment has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets [Phase 4]
A Phase 4 prospective biomarker study in active secondary progressive multiple sclerosis patients treated with cladribine tablets.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: A Study to Provide Complementary Efficacy, Safety and Patient Reported Outcomes Data in Participants With Active Relapsing Forms of Multiple Sclerosis (MS) in a Pragmatic Setting [Phase 4]
Phase 4 trial update collecting complementary efficacy, safety, and patient-reported outcomes in active relapsing forms of multiple sclerosi…
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment [Phase 3]
Phase 3 trial update on ADS-5102 for walking impairment in multiple sclerosis; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-11-22Clinical Trial Update: Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis [Phase 2]
Phase 2 trial assessing AVP-923 for central neuropathic pain in multiple sclerosis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-11-16Clinical Trial Update: Phase IV Study, Betaseron Versus Copaxone for Relapsing Remitting or CIS Forms of MS Using Triple Dose Gad 3 T MRI [Phase 4]
Phase IV trial comparing Betaseron versus Copaxone in relapsing forms of multiple sclerosis using triple-dose gadolinium MRI.
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) [Phase 3]
Phase 3 trial update evaluating safety and efficacy of orally administered laquinimod versus placebo in relapsing-remitting multiple scleros…
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Effects of Teriflunomide (Aubagio) on Cognitive and Vocational Outcomes in Multiple Sclerosis
Clinical trial assessing teriflunomide (Aubagio) impact on cognitive and vocational outcomes in multiple sclerosis has completed with result…
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Tecfidera and the Gut Microbiota [Phase 4]
Phase 4 clinical trial update on Tecfidera (dimethyl fumarate) and its relationship with the gut microbiota in relapsing multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS Patients [Phase 4]
Phase 4 study evaluation of [18F]Florbetapir PET feasibility for assessing multiple sclerosis; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: A Positive Psychology Intervention for Patients With Multiple Sclerosis [NA]
A completed clinical trial assessing a positive psychology intervention for patients with multiple sclerosis; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: Imatinib for Multiple Sclerosis (MS) Relapses [Phase 2]
Phase 2 clinical trial evaluating imatinib for multiple sclerosis relapses is in an unknown status.
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: Visual Reconstitution Therapy After Optic Neuritis [Phase 2]
Phase 2 trial update on visual reconstitution therapy for optic neuritis, with conditions including optic neuritis and multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: Sunphenon in Progressive Forms of Multiple Sclerosis [Phase 2, Phase 3]
Clinical trial update for Sunphenon in progressive forms of multiple sclerosis, encompassing Phase 2 and Phase 3 completion.
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: MOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study) [Phase 2, Phase 3]
Clinical trial MOVING evaluating modification of visual outcomes after optic neuritis in CIS or MS using Gilenya; terminated study phase 2/3…
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue [Phase 1, Phase 2]
A clinical trial investigating microglial activation and norepinephrine transporter abnormalities as factors in multiple sclerosis-related f…
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab [Phase 4]
A Phase 4 pilot study evaluating the biological effects of a planned 12-week interruption of natalizumab in patients with relapsing forms of…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis [Phase 2]
This Phase 2 trial update reports results for clemastine fumarate as a remyelinating agent in relapsing-remitting multiple sclerosis, with r…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Phase IIa Study of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis [Phase 2]
Phase IIa trial of Ublituximab in relapsing forms of multiple sclerosis completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis [Phase 3]
A Phase 3 head-to-head trial comparing oral ponesimod with teriflunomide in relapsing multiple sclerosis has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Home Based Infusions for Ocrelizumab [Phase 4]
Phase 4 clinical trial evaluating home-based infusions of ocrelizumab for multiple sclerosis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2021-05-27Clinical Trial Update: Evaluation of the Onset of Action in Highly Active MS (MAGNIFY) [Phase 4]
Phase 4 clinical trial update evaluating onset of action in highly active multiple sclerosis; completed with posted results.